ODERDA, Marco
 Distribuzione geografica
Continente #
NA - Nord America 8.645
AS - Asia 5.805
EU - Europa 4.149
SA - Sud America 796
AF - Africa 132
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.592
Nazione #
US - Stati Uniti d'America 8.397
SG - Singapore 2.269
CN - Cina 1.521
IT - Italia 1.009
VN - Vietnam 638
BR - Brasile 606
FR - Francia 566
IE - Irlanda 444
DE - Germania 381
SE - Svezia 363
KR - Corea 304
GB - Regno Unito 242
IN - India 229
HK - Hong Kong 199
FI - Finlandia 181
DK - Danimarca 177
AT - Austria 148
UA - Ucraina 139
BD - Bangladesh 126
CA - Canada 125
JP - Giappone 93
ID - Indonesia 91
MX - Messico 86
NL - Olanda 83
PL - Polonia 83
AR - Argentina 68
ES - Italia 67
TR - Turchia 60
BE - Belgio 54
RU - Federazione Russa 54
AU - Australia 53
IQ - Iraq 42
EC - Ecuador 27
PK - Pakistan 27
ZA - Sudafrica 26
CO - Colombia 24
CL - Cile 22
SA - Arabia Saudita 22
CH - Svizzera 21
GR - Grecia 21
PT - Portogallo 21
UZ - Uzbekistan 20
AE - Emirati Arabi Uniti 18
EG - Egitto 18
VE - Venezuela 16
IL - Israele 15
MA - Marocco 14
PH - Filippine 14
JO - Giordania 13
MY - Malesia 13
RO - Romania 13
TN - Tunisia 13
TW - Taiwan 12
TH - Thailandia 11
LT - Lituania 10
PE - Perù 10
SN - Senegal 10
AZ - Azerbaigian 9
IR - Iran 9
JM - Giamaica 9
PY - Paraguay 9
CZ - Repubblica Ceca 8
EE - Estonia 8
NO - Norvegia 7
UY - Uruguay 7
AL - Albania 6
ET - Etiopia 6
HR - Croazia 6
HU - Ungheria 6
NP - Nepal 6
OM - Oman 6
BY - Bielorussia 5
DZ - Algeria 5
KE - Kenya 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
TZ - Tanzania 5
BH - Bahrain 4
BO - Bolivia 4
BW - Botswana 4
CI - Costa d'Avorio 4
GI - Gibilterra 4
KZ - Kazakistan 4
PA - Panama 4
QA - Qatar 4
RS - Serbia 4
TT - Trinidad e Tobago 4
KG - Kirghizistan 3
LB - Libano 3
LC - Santa Lucia 3
LK - Sri Lanka 3
LV - Lettonia 3
MK - Macedonia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
CU - Cuba 2
Totale 19.538
Città #
Singapore 1.277
Chandler 972
Ashburn 753
San Jose 597
Beijing 588
Santa Clara 581
Dublin 439
Ann Arbor 345
Seoul 212
Torino 199
Hefei 197
Ho Chi Minh City 195
Houston 189
Dallas 186
Fairfield 179
Wilmington 179
Nyköping 170
Villeurbanne 169
Lauterbourg 165
Hong Kong 150
The Dalles 144
Los Angeles 143
Hanoi 140
Turin 138
Dearborn 136
Vienna 135
Columbus 134
Jacksonville 118
Princeton 117
Munich 106
Medford 100
Seattle 97
Buffalo 96
Woodbridge 86
Milan 85
New York 83
Orem 80
Bengaluru 75
Cambridge 70
Guangzhou 67
Warsaw 63
São Paulo 61
Boardman 59
Boston 56
Jakarta 56
Shanghai 54
Pisa 50
Tokyo 49
Redondo Beach 48
Council Bluffs 44
Frankfurt am Main 44
Rome 43
Chicago 42
Dong Ket 40
Fremont 38
Chennai 37
Helsinki 36
Montreal 36
Brussels 35
Hangzhou 35
Turku 35
Redwood City 34
Atlanta 31
Haiphong 31
Nuremberg 30
Paris 30
Washington 30
London 29
Norwalk 28
Pune 28
Toronto 27
Manchester 26
Mexico City 25
Nanjing 25
Phoenix 25
Da Nang 24
Rio de Janeiro 24
Suzhou 24
Amsterdam 23
Lappeenranta 23
Brooklyn 22
Düsseldorf 22
Silver Spring 21
Naples 20
Chengdu 19
San Diego 19
Memphis 18
Belo Horizonte 17
San Francisco 17
Stockholm 17
Hebei 15
Istanbul 15
Johannesburg 15
Mumbai 15
Wayne 15
Baghdad 14
Berlin 14
Bologna 14
Frisco 14
Hải Dương 14
Totale 11.707
Nome #
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? 552
Urological consequences following renal transplantation: a review of the literature 452
Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database 400
microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes 383
H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer 354
MMP23B expression and protein levels in blood and urine are associated with bladder cancer 341
A Comparative Study Between 2 Different Grafts Used as Patches After Plaque Incision and Inflatable Penile Prosthesis Implantation for End-Stage Peyronie's Disease 295
A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the 'sliding' technique for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction 292
Urine microRNA profiling in bladder cancer by next-generation sequencing 272
Non-invasive methods of penile lengthening: fact or fiction? 265
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up 244
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication 242
DKK-1 in prostate cancer diagnosis and follow up 238
Sexual function after surgical treatment for penile cancer: Which organ-sparing approach gives the best results? 230
Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer? 227
A Single-center Analysis on the Learning Curve of Male-to-Female Penoscrotal Vaginoplasty by Multiple Surgical Measures 216
The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer 214
Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis. 192
Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer 187
Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study 179
Abstract 778: DNA repair capacity, chromosomal damage, methylation and gene expression levels in bladder cancer: An integrated analysis 179
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy 165
The strange case of a hematocele mistaken for a neoplastic scrotal mass 163
Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries? 158
Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study 157
Renal artery aneurysm treated with laparoscopic nephrectomy, ex vivo repair and autotransplantation. 152
Low levels of urinary psa better identify prostate cancer patients 152
Surgical management of hypogonadic patients with hypotrophic testicles and small penis: A novel, combined technique with an infrapubic approach 150
Tubulocystic renal cell carcinoma disguised as a renal cyst 150
Small non-coding RNA profiling in plasma extracellular vesicles of bladder cancer patients by next-generation sequencing: Expression levels of miR-126-3p and piR-5936 increase with higher histologic grades 150
The impact of single-use digital flexible cystoscope for double J removal on hospital costs and work organization: A multicentric evaluation 149
TREATMENT OF PROSTATE CANCER AND SEXUAL REHABILITATION WHEN A NERVE-SPARING PROCEDURE IS NOT FEASIBLE: PLACEMENT OF THE RESERVOIR FOR A THREE-COMPONENT PENILE IMPLANT DURING ROBOTIC EXTRA-APONEUROTIC RADICAL PROSTATECTOMY 143
The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study Protocol 141
Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series. 141
[Neuroendocrine bladder cancer: oncological emergency?] 141
The importance of psychosexual counselling in the re-establishment of organic and erotic functions after penile prosthesis implantation 138
Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection 137
mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging 135
COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center 134
Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer? 133
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy 133
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort 131
Cell-cycle Progression-Score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients 131
Active surveillance for small renal tumors: Have clinical concerns been addressed so far? 131
How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy 130
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 128
A review on the management of small renal masses: active surveillance versus surgery 127
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 126
The impact of warmed and humidified CO2 insufflation during robotic radical prostatectomy: Results of a randomized controlled trial 125
Awake Da Vinci robotic partial nephrectomy: First case report ever in a situation of need 125
Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review 123
Comment On: Applying Extender Devices in Patients with Penile Dysmorphophobia: Assessment of Tolerability, Efficacy, and Impact on Erectile Function 122
Robot-assisted laparoscopic pyeloplasty in a pediatric patient with horseshoe kidney: surgical technique and review of the literature 121
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients 121
Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort 120
Effects of warmed, humidified CO2 insufflation on body core temperature and cytokine response: Head-to-head randomized comparison vs. standard insufflation during RARP 120
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer 119
Advice on the counseling of patients seeking treatment for short penis. 119
[Two cases of retroperitoneal metastasis from a completely regressed burned-out testicular cancer.] 119
Laparoscopic management of sacral neurinoma causing hydronephrosis 119
Osteoclast-Like Giant Cell Carcinoma Hidden by a Bladder Stone in a Patient with Neurogenic Bladder 118
Natural history of widespread high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: should we rebiopsy them all? 118
Nightmares in Salvage Robot-assisted Radical Prostatectomy After Primary Radiation Therapy for Prostate Cancer: A Step by Step Tutorial 118
Hyperthermia for non-muscle invasive bladder cancer 117
First ever reported case of continuous spinal anesthesia da Vinci robotic partial nephrectomy 116
Allium stent for the treatment of a malignant ureteral stenosis: a paradigmatic case 116
Iliac artery-ureteral fistula: a fatal hemorrhage in a man with ureterocutaneostomy 115
Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study 112
Predictors of Bone Metastases at68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence 112
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study 112
Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation 110
Update on epidemiology and risk factors of prostate cancer 109
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion 109
Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over 107
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches 103
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy 102
Predictors of Prostate Cancer at Fusion Biopsy: The Role of Positive Family History, Hypertension, Diabetes, and Body Mass Index 102
Pain in Men Undergoing Transperineal Free-Hand Multiparametric Magnetic Resonance Imaging Fusion Targeted Biopsies under Local Anesthesia: Outcomes and Predictors from a Multicenter Study of 1,008 Patients 101
Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy 100
Transperineal Free-hand mpMRI Fusion-targeted Biopsies Under Local Anesthesia: Technique and Feasibility From a Single-center Prospective Study 100
Surgical Outcomes of Glansectomy and Split Thickness Skin Graft Reconstruction for Localized Penile Cancer 99
Appropriateness and complications of androgen deprivation therapy for prostate cancer: Can we do better? A retrospective observational analysis from a referral center 95
Lateral versus anterior approach for bladder neck dissection during robot-assisted radical prostatectomy: a pair-matched analysis to evaluate urinary continence and surgical margins 95
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin 95
Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager 94
Impact of operator expertise on transperineal free-hand mpMRI-fusion-targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicenter prospective learning curve 94
Intraoperative 3D-US-mpMRI Elastic Fusion Imaging-Guided Robotic Radical Prostatectomy: A Pilot Study 92
The impact of intravesical Gemcitabine and 1/3 dose Bacillus Calmette Guerin instillation therapy on the quality of life in non-muscle-invasive bladder cancer patients: results of a prospective, randomised phase II trial. 92
Retroperitoneal laparoscopic kidney biopsy: technical tips for a minimally invasive approach. 89
Debulking surgery in the setting of very high-risk prostate cancer scenarios 89
AUTHOR REPLY 89
European Association for Endoscopic Surgery (EAES) consensus on Indocyanine Green (ICG) fluorescence-guided surgery 88
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series 88
Radical Prostatectomy for Nonmetastatic Prostate Cancer in Renal Transplant Recipients: Outcomes for a Large Contemporary Cohort and a Matched Comparison to Patients Without a Transplant 88
Single-use digital flexible cystoscope for double J removal versus reusable instruments: a prospective, comparative study of functionality, risk of infection, and costs 88
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study 88
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma. 85
Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT 85
Cost-effectiveness analysis of a single-use digital flexible cystoscope for double J removal 84
Fatal haematuria in a patient with an orthotopic neobladder and chronic liver failure 84
Totale 15.231
Categoria #
all - tutte 69.921
article - articoli 0
book - libri 0
conference - conferenze 996
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 0 109
2021/20221.258 33 40 58 83 60 45 61 74 28 81 424 271
2022/20232.448 236 315 54 259 228 561 171 146 238 62 121 57
2023/20241.110 145 177 62 67 68 148 65 31 19 76 83 169
2024/20253.496 54 189 122 246 774 237 103 168 415 238 316 634
2025/20267.574 801 577 546 992 811 411 1.053 335 660 588 525 275
Totale 20.145